Semaglutide is a GLP-1 receptor agonist that has fundamentally changed the weight management landscape. Originally developed for type 2 diabetes, clinical trials showed average body weight reductions of 15-17%, making it the most effective pharmaceutical weight loss intervention in decades.
How Semaglutide Works
Your gut produces a hormone called GLP-1 (glucagon-like peptide-1) after you eat. It signals to your brain that you're full, slows gastric emptying so food stays in your stomach longer, and helps regulate insulin secretion.
Semaglutide mimics this hormone, but with a much longer half-life. Instead of the fleeting signal your gut produces after a meal, semaglutide provides a sustained, consistent signal that:
- Reduces appetite — you genuinely feel less hungry, not through willpower but through biology
- Quiets food noise — the constant background thinking about food decreases significantly
- Slows gastric emptying — food stays in your stomach longer, so you feel full sooner and stay full longer
- Improves insulin sensitivity — better blood sugar control, which has cascading metabolic benefits
The Clinical Evidence
The STEP clinical trial program (STEP 1 through STEP 5, plus the SELECT cardiovascular outcomes trial) established semaglutide as a clinically proven weight management tool:
- STEP 1: — 15.3% average body weight reduction over 68 weeks
- STEP 2: — 9.6% in participants with type 2 diabetes
- STEP 3: — 16% when combined with intensive behavioral therapy
- SELECT: — 20% reduction in major cardiovascular events
These aren't cherry-picked results — they're from large-scale, placebo-controlled trials with thousands of participants.
What to Expect: A Realistic Timeline
Week 1-2: You start at a lower dose. Appetite begins to decrease. Some people experience mild nausea as the body adjusts — this is normal and typically resolves.
Week 3-4: Dose titration continues. Appetite suppression becomes more consistent. You'll notice you're naturally eating less without forcing it. Cravings, especially for high-calorie foods, start to diminish.
Week 6-8: Meaningful weight loss becomes visible. Eating patterns have naturally shifted. Energy levels often improve as metabolic health improves.
Week 12-16: Significant body composition changes. Most GI side effects have resolved. Metabolic markers (blood sugar, lipids) begin improving.
Week 24+: Sustained weight management. Clinical trials show continued progress through 68 weeks of consistent use.
Side Effects
The most common side effects are GI-related: nausea, occasional vomiting, diarrhea, or constipation. These are dose-dependent and typically worst during the titration period. Our care team starts you on a lower dose and increases gradually to minimize discomfort.
Most members report that GI side effects resolve within the first 4-6 weeks as the body adjusts.
How We Do It at Derive
We offer semaglutide as Contour — starting at $199/month. Our care team reviews your profile, manages your dose titration, and monitors your progress throughout. Every batch is compounded from pharmaceutical-grade API and independently tested.
HSA/FSA eligible. Ships free. Cancel anytime.